Search Results - CHEMOTHERAPEUTICS DERMATOLOGICALS AND IMMUNOLOGICALS

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement by Emilio Alvarez-Cuesta, MD, PhD, MQM, Ricardo Madrigal-Burgaleta, LMS, MD, PhD, Ana D. Broyles, MD, Javier Cuesta-Herranz, MD, PhD, Maria Antonieta Guzman-Melendez, MD, PhD, Michelle C. Maciag, MD, Elizabeth J. Phillips, MD, Jason A. Trubiano, MBBS, PhD, Johnson T. Wong, MD, Ignacio Ansotegui, MD, PhD, F. Runa Ali, MBBS, PhD, FRCP, Denisse Angel-Pereira, MD, Aleena Banerji, MD, Maria Pilar Berges-Gimeno, MD, PhD, Lorena Bernal-Rubio, MD, Knut Brockow, MD, Ricardo Cardona Villa, MD, Mariana C. Castells, MD, PhD, Jean-Christoph Caubet, MD, Yoon-Seok Chang, MD, PhD, Luis Felipe Ensina, MD, MSc, PhD, Manana Chikhladze, PhD, Anca Mirela Chiriac, MD, PhD, Weng-Hung Chung, MD, PhD, Motohiro Ebisawa, MD, PhD, Bryan Fernandes, MBBS, MRCP, Lene Heise Garvey, MD, PhD, Maximiliano Gomez, MD, PhD, Javier Gomez Vera, MD, Sandra Gonzalez Diaz, MD, PhD, David I. Hong, MD, Juan Carlos Ivancevich, MD, Hye-Ryun Kang, MD, PhD, David A. Khan, MD, Merin Kuruvilla, MD, Jose Ignacio Larco Sousa, MD, Patricia Latour-Staffeld, MD, Anne Y. Liu, MD, Eric Macy, MD, Hans Jorgen Malling, MD, Jorge Maspero, MD, Sara M. May, MD, Cristobalina Mayorga, PhD, Miguel A. Park, MD, Jonathan Peter, MBChB, PhD, Matthieu Picard, MD, FRCPC, Tito Rodriguez-Bouza, MD, PhD, Antonino Romano, MD, Mario Sanchez-Borges, MD, Luciana Kase Tanno, MD, PhD, Maria Jose Torres, MD, PhD, Alicia Ureña-Tavera, MD, Rocco L. Valluzzi, MD, Gerald W. Volcheck, MD, Masao Yamaguchi, MD, PhD

    Published in World Allergy Organization Journal (2022-06-01)
    Get full text
    Article
  5. 5
  6. 6

    A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole by Mohsin Hamid, Bilal Lashari, Irfan Ahsan, Ida Micaily, Usman Sarwar, Joseph Crocetti

    “…Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

Search Tools: